GALECTIN THERAPEUTICS INC. Proceeds from Issuance of Warrants
GALECTIN THERAPEUTICS INC. (GALT) reported Proceeds from Issuance of Warrants of $2.50 million for the 1-month period ending 2019-05-31, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2021-08-16
- 2019-05-31: Proceeds from Issuance of Warrants 1 month $2.50M.
- 2019-05-19: Proceeds from Issuance of Warrants $2.50M.
- 2008-07-02: Proceeds from Issuance of Warrants 0 month $20.00K; Proceeds from Issuance of Warrants 1 month $20.00K.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 1 month |
|---|---|---|---|
| 2019-05-31 | $2.50M 10-Q · filed 2019-11-12 | ||
| 2019-05-19 | $2.50M 10-Q · filed 2021-08-16 | ||
| 2008-07-02 | $20.00K 10-K · filed 2014-03-21 | $20.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |